The discovery of MOTS-c in 2015 fundamentally changed our understanding of mitochondrial signaling. As the first peptide encoded within the mitochondrial genome shown to translocate to the nucleus and regulate gene expression, MOTS-c revealed that mitochondria communicate with the nuclear genome through peptide signals — a finding with profound implications for metabolic and aging research.
Discovery and Significance
MOTS-c was identified by Changhan Lee and colleagues at the University of Southern California when they discovered that the mitochondrial 12S rRNA gene contains an open reading frame encoding a 16-amino acid peptide. This was unexpected because mitochondrial rRNA was thought to function exclusively as a structural component of mitochondrial ribosomes. The finding that it also encodes a bioactive signaling peptide introduced the concept of mitochondrial-derived peptides (MDPs) as a new class of retrograde signaling molecules (Lee et al., 2015; PMID: 25738459).
AMPK Activation: The Exercise Connection
MOTS-c's primary documented mechanism is activation of AMPK (AMP-activated protein kinase), the master cellular energy sensor. AMPK activation triggers a cascade of metabolic adaptations: increased glucose uptake, enhanced fatty acid oxidation, mitochondrial biogenesis, and inhibition of energy-consuming anabolic processes. These are the same adaptations produced by physical exercise, earning MOTS-c the designation of "exercise mimetic" in published literature.
Critically, MOTS-c was shown to translocate from mitochondria to the nucleus under metabolic stress, where it directly regulates nuclear gene expression — specifically genes involved in the folate cycle and de novo purine biosynthesis. This retrograde mitochondria-to-nucleus signaling represents a novel communication pathway (Lee et al., 2015).
Metabolic Research Applications
In diet-induced obesity models, MOTS-c treatment prevented weight gain, improved insulin sensitivity, and reduced hepatic lipid accumulation. In aged mice, MOTS-c administration improved physical performance on treadmill tests and restored metabolic parameters toward youthful levels. The peptide's effects on glucose homeostasis are particularly robust — it enhances both insulin-dependent and insulin-independent glucose uptake mechanisms.
Aging Research
MOTS-c levels decline with age in both rodent and human studies, paralleling the decline in metabolic function and exercise capacity. This age-related decline, combined with the peptide's ability to restore metabolic parameters in aged models, has made MOTS-c a focus of geroscience research. The concept that a mitochondrial-encoded peptide might serve as a circulating "mitokine" linking mitochondrial function to systemic metabolism is actively being investigated.
Research-Grade MOTS-c
MOTS-c is available in 10mg and 40mg lyophilized vials at systemicpeptides.com.
References
- Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-54. PMID: 25738459
- Kim KH, et al. Mitochondrial-derived peptides in aging and age-related diseases. GeroScience. 2021;43(3):1113-21. PMID: 33051835